相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Gasdermin D-mediated pyroptosis suppresses liver regeneration after 70% partial hepatectomy
Xingyu Lv et al.
HEPATOLOGY COMMUNICATIONS (2022)
Redundant Functions of ERK1 and ERK2 Maintain Mouse Liver Homeostasis Through Down-Regulation of Bile Acid Synthesis
Francesca Cingolani et al.
HEPATOLOGY COMMUNICATIONS (2022)
Integrative genomics highlights opportunities for innovative therapies targeting the tumor microenvironment in gallbladder cancer
Stephanie Roessler et al.
JOURNAL OF HEPATOLOGY (2021)
Chemotherapy for advanced gallbladder cancer (GBC): A systematic review and meta-analysis
Alexander A. Azizi et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2021)
Induction of Apoptosis by Isoalantolactone in Human Hepatocellular Carcinoma Hep3B Cells through Activation of the ROS-Dependent JNK Signaling Pathway
Min Yeong Kim et al.
PHARMACEUTICS (2021)
Interplay between MAPK/ERK signaling pathway and MicroRNAs: A crucial mechanism regulating cancer cell metabolism and tumor progression
Elmira Roshani Asl et al.
LIFE SCIENCES (2021)
Treatment of advanced gallbladder cancer: A SEER-based study
Weipu Mao et al.
CANCER MEDICINE (2020)
Isoalantolactone inhibits RANKL-induced osteoclast formation via multiple signaling pathways
Jinwei Lu et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2020)
Overview of current targeted therapy in gallbladder cancer
Xiaoling Song et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
Loss of c-Jun N-terminal Kinase 1 and 2 Function in Liver Epithelial Cells Triggers Biliary Hyperproliferation Resembling Cholangiocarcinoma
Francisco Javier Cubero et al.
HEPATOLOGY COMMUNICATIONS (2020)
Anti-tumor Activity of Bufalin by Inhibiting c-MET Mediated MEK/ERK and PI3K/AKT Signaling Pathways in Gallbladder Cancer
Liqiang Qian et al.
JOURNAL OF CANCER (2020)
A Novel Nomogram Predicting Distant Metastasis in T1 and T2 Gallbladder Cancer: A SEER-based Study
Yu-Long Cai et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Isoalantolactone suppresses LPS-induced inflammation by inhibiting TRAF6 ubiquitination and alleviates acute lung injury
Yun-he Ding et al.
ACTA PHARMACOLOGICA SINICA (2019)
PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR/CCL2 pathway
Hui Shen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Aberrant N-cadherin expression in cancer
Zhan-Qi Cao et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer
Anushka Dongre et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
Somatic genetic aberrations in gallbladder cancer: comparison between Chinese and US patients
Pingzhou Yang et al.
HEPATOBILIARY SURGERY AND NUTRITION (2019)
Isoalantolactone induces apoptosis through reactive oxygen species-dependent upregulation of death receptor 5 in human esophageal cancer cells
Zhengyang Lu et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Gallbladder Cancer
Ioana Baiu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Isoalantolactone induces apoptosis through ROS-mediated ER stress and inhibition of STAT3 in prostate cancer cells
Wei Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Alantolactone and Isoalantolactone Prevent Amyloid 25-35-induced Toxicity in Mouse Cortical Neurons and Scopolamine-induced Cognitive Impairment in Mice
Ji Yeon Seo et al.
PHYTOTHERAPY RESEARCH (2017)
Demystifying traditional herbal medicine with modern approaches
Fu-Shuang Li et al.
NATURE PLANTS (2017)
Isoalantolactone induces autophagic cell death in SKOV3 human ovarian carcinoma cells via upregulation of PEA-15
Zhiyong Weng et al.
ONCOLOGY REPORTS (2016)
Isoalantolactone induces apoptosis in human breast cancer cells via ROS-mediated mitochondrial pathway and downregulation of SIRT1
Ziliang Li et al.
ARCHIVES OF PHARMACAL RESEARCH (2016)
SHANK3 controls maturation of social reward circuits in the VTA
Sebastiano Bariselli et al.
NATURE NEUROSCIENCE (2016)
Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-B signaling pathway
Jing Wang et al.
ONCOLOGY REPORTS (2016)
Compromised MAPK signaling in human diseases: an update
Eun Kyung Kim et al.
ARCHIVES OF TOXICOLOGY (2015)
Isoalantolactone Induces Reactive Oxygen Species Mediated Apoptosis in Pancreatic Carcinoma PANC-1 Cells
Muhammad Khan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2012)
Vimentin in cancer and its potential as a molecular target for cancer therapy
Arun Satelli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Raf-induced MMP9 disrupts tissue architecture of human breast cells in three-dimensional culture and is necessary for tumor growth in vivo
Alain Beliveau et al.
GENES & DEVELOPMENT (2010)
The BRAFV600E Oncogene Induces Transforming Growth Factor β Secretion Leading to Sodium Iodide Symporter Repression and Increased Malignancy in Thyroid Cancer
Garcilaso Riesco-Eizaguirre et al.
CANCER RESEARCH (2009)
B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic β-cell carcinogenesis
I. Sobczak et al.
ONCOGENE (2008)
Raf-1 regulates Rho signaling and cell migration
K Ehrenreiter et al.
JOURNAL OF CELL BIOLOGY (2005)
B-raf acts via the ROCKII/LIMK/cofilin pathway to maintain actin stress fibers in fibroblasts
CA Pritchard et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Raf induces TGFβ production while blocking its apoptotic but not invasive responses:: a mechanism leading to increased malignancy in epithelial cells
K Lehmann et al.
GENES & DEVELOPMENT (2000)
分享论文
